
Amy Errett Joins Pendulum Therapeutics Board to Scale Microbiome Health
As consumer interest in the gut microbiome shifts from niche research to mainstream health, San Francisco-based biotechnology firm Pendulum Therapeutics has tapped Madison Reed founder Amy Errett to join its board of directors, signaling a strategic push to transform its clinical science into a household consumer brand.


























